AstraZeneca And Institute Kanser Negara Partner to Introduce AI Technology For Lung Screening

Vinod_Narayanan___Country_President__AstraZeneca_Malaysia__together_with_Dr__Puteri_Norliza Lung screening
In conjunction with Institut Kanser Negara’s (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

covid-19 booster asia
Should I Get a COVID-19 Booster Shot? Experts from Asia Weigh In

Dr. Silverose Ann Bacolcol, Head of Manila Doctors’ Hospital Infection Prevention and Control Office, shared that “Most of the COVID-19 cases we see now are mild to moderate infections and can be managed at home. However, patients who have risk factors for disease progression, such as the elderly, those with co-morbid conditions, and are immunocompromised, need close monitoring and may have to be admitted.”

Dr Bacolcol strongly advised to receive a booster shot. She stated, “people should still receive their booster shots for COVID-19 because the threat of COVID-19 infection still exists and will continue to stay. The US CDC and Philippine DOH recommend the COVID-19 booster to prevent serious illness, hospitalisation, and death due to COVID-19.” About 23 million Filipinos have received a booster shot.

Read More »